A Phase I Study of NLG919 for Adult Patients With Recurrent Advanced Solid Tumors
Journal for ImmunoTherapy of Cancer - United Kingdom
doi 10.1186/2051-1426-2-s3-p250
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2014
Authors
Publisher
BMJ